Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Tornier Inc. the operating subsidiary of Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated Affiniti^TM Stem for shoulder joint replacement surgery. The Porous Coated Stem, which facilitates device fixation to bone without bone cement, addresses the large segment of the market represented by patients for whom fixation with bone cement may be problematic. With the expanded Affiniti product line and the renowned Aequalis^TM product line, Tornier provides surgeons and their patients a choice of shoulder arthroplasty systems that is among the widest in the industry.

R. Sean Churchill, MD, orthopaedic surgeon and shoulder surgery specialist at Aurora Advanced Healthcare in Milwaukee, WI, commented, "As a shoulder specialist, I find the treatment of patients with osteoporosis to be very challenging. Utilizing the Tornier Porous Coated Affiniti Stem allows me to avoid cement in the vast majority of these patients. The product's secure press fit with porous coating allows bone growth onto the implant, improving fixation without the added risks and complications of cement."

The Porous Coated Affiniti Stem expands Tornier's successful Affiniti shoulder product line that was launched in 2008. The Affiniti product line features innovative humeral stem and glenoid component designs as well as advanced instrumentation to maximize both accurate implant positioning and ease of use. The Porous Coated Affiniti Stem was designed not only to allow increased bone fixation for improved implant longevity without cement, but to also reduce bone loss if the patient requires revision surgery in the future.